Merck (MRK) Revenue (2009 - 2026)

Merck has disclosed Revenue across 18 years of filings, most recently posting $16.3 billion for Q1 2026.

• In Q1 2026, Revenue rose 4.87% year-over-year to $16.3 billion; the TTM figure through Mar 2026 stood at $65.8 billion (up 2.89% YoY), while the FY2025 annual figure was $65.0 billion, up 1.31% from the prior year.
• Revenue fell to $16.3 billion in Q1 2026, from $16.4 billion in the prior quarter.
• Over the last five years, Revenue for MRK reached as high as $17.3 billion in Q3 2025 and fell as low as $13.8 billion in Q4 2022.
• The 5-year median for Revenue is $15.8 billion (2024), against an average of $15.6 billion.
• Annual changes were most pronounced in 2022 — Revenue jumped 49.63% — and 2023, when it dropped 8.89%.
• A 5-year view of Revenue shows it stood at $13.8 billion in 2022, then gained by 5.78% to $14.6 billion in 2023, then climbed by 6.79% to $15.6 billion in 2024, then grew by 4.97% to $16.4 billion in 2025, then declined by 0.7% to $16.3 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $16.3 billion, $16.4 billion, and $17.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.